C Champions Oncology Inc
C
Fechado
SetorSaúde
6.26 1.29
Visão Geral
Variação de preço das ações
24h
Mín
5.45
Máximo
6.41
Rendimento | -514K -278K |
|---|---|
Vendas | 1.5M 17M |
P/E Médio do Setor | 35.118 50.958 |
EPS | -0.02 |
Margem de lucro | -1.679 |
Funcionários | 213 |
EBITDA | -508K 104K |
Próximos Ganhos | 22 de jul. de 2026 |
|---|
Capitalização de Mercado | 3.9M 87M |
|---|---|
Abertura anterior | 4.97 |
Fecho anterior | 6.26 |
Sentimento de Notícias
By Acuity
100%
0%
323 / 342 Ranking em Healthcare
Champions Oncology Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.